Alert-Based Computerized Decision Support for Identification and Management of Patients With Familial Hypercholesterolemia (FH-ALERT Trial)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Familial Hypercholesterolaemia
- Sponsor
- Brigham and Women's Hospital
- Enrollment
- 450
- Locations
- 1
- Primary Endpoint
- Frequency of documented FH diagnosis
- Status
- Recruiting
- Last Updated
- 7 months ago
Overview
Brief Summary
The goal of this clinical trial is to learn if a computer alert can aid clinicians in identifying patients with a genetic type of high cholesterol, called Familial Hypercholesterolemia. The main question it aims to answer is whether the computer alert increases recognition of this high cholesterol disorder.
Detailed Description
FH-ALERT is a single-center, time-series trial of a patient- and provider-facing EPIC BPA (alert-based CDS tool) to increase diagnosis, LDL-C lowering, and guideline-based therapy of outpatients with presentations consistent with FH. For the first 6 months, the BPA will run in "silent mode", identifying patients with presentations consistent with FH, but not alerting the clinician of record. Following this initial "pre-alert" 6-month period, the BPA will switch to "alert mode" for 18 months, which will provide the on-screen notification to the clinician of record. In other words, consecutive outpatients with presentations consistent with FH will be enrolled over two years: "pre-alert" (silent mode) for 6 months and "alert mode" for 18 months.
Investigators
Gregory Piazza, MD, MS
Staff Physician
Brigham and Women's Hospital
Eligibility Criteria
Inclusion Criteria
- •≥ 18 years old
- •seen in the BWH Endocrinology, Cardiovascular Medicine, and Primary Care Clinics
- •Dutch Lipid Clinic Network score of at least 3 points
Exclusion Criteria
- •a Familial Hypercholesterolemia diagnosis already documented in the EHR medical history, visit history, or problem list
Outcomes
Primary Outcomes
Frequency of documented FH diagnosis
Time Frame: 6 Months
We will review the medical history, visit diagnosis, and problem list sections of the Electronic Health Record (EPIC) to make this determination of diagnosis of Familial Hypercholesterolemia.
Secondary Outcomes
- Mean Change in LDL-C(6 Months)